Topic update: this evaluation has not been defined as therapeutically critical (please follow the link titled rapid guidelines and evidence summaries within the yellow banner at the top of the page for information on recent changes to the way we work). The HST evaluation will progress as planned with company and Evidence Review Group input into the next phase of the timeline. NICE will provide further updates on the progress of the evaluation when known.